{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:28:36Z","timestamp":1774679316024,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101127","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:51:08Z","timestamp":1770943868000},"page":"101127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between dose to specific pelvic substructures and urinary and sexual dysfunction following Single-Dose ablative radiotherapy for prostate Cancer: A post hoc analysis from the ABRUPT trial"],"prefix":"10.1016","volume":"58","author":[{"given":"Stefano","family":"Arcangeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9584-637X","authenticated-orcid":false,"given":"Valeria","family":"Faccenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0319-599X","authenticated-orcid":false,"given":"Federica","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Chissotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8774-9457","authenticated-orcid":false,"given":"Lorenzo","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1330-8416","authenticated-orcid":false,"given":"Giulia","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9387-5785","authenticated-orcid":false,"given":"Elena","family":"Arcieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2434-2753","authenticated-orcid":false,"given":"Valerio","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3867-2844","authenticated-orcid":false,"given":"Riccardo Ray","family":"Colciago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"De Ponti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8309-924X","authenticated-orcid":false,"given":"Denis","family":"Panizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ctro.2026.101127_b0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2026.101127_b0010","doi-asserted-by":"crossref","unstructured":"Fransson P, Nilsson P, Gunnlaugsson A, et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.Lancet Oncol. https:\/\/doi.org\/10.1016\/s1470-2045(20)30581-7.","DOI":"10.1016\/S1470-2045(20)30581-7"},{"key":"10.1016\/j.ctro.2026.101127_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110568","article-title":"Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial","volume":"201","author":"Draulans","year":"2024","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101127_b0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(25)00205-0","article-title":"Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial","volume":"26","author":"Tree","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101127_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2021.07.004","article-title":"Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: results of a prospective Randomized phase 3 Clinical Trial, NRG\/RTOG 0126","volume":"112","author":"Hall","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101127_b0030","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101127_b0035","doi-asserted-by":"crossref","unstructured":"Schaake W, van der Schaaf A, van Dijk LV, van den Bergh ACM, Langendijk JA. Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.PLoS One. 2018;13(7):e0197757. Published 2018 Jul 17. https:\/\/doi.org\/10.1371\/journal.pone.0197757.","DOI":"10.1371\/journal.pone.0197757"},{"issue":"1","key":"10.1016\/j.ctro.2026.101127_b0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mp.16878","article-title":"Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis","volume":"51","author":"Pham","year":"2024","journal-title":"Med Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101127_b0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.eururo.2017.02.007","article-title":"Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: a Single-arm phase 2 Trial","volume":"72","author":"Spratt","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101127_b0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2020.01.022","article-title":"Erectile Dysfunction and absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer","volume":"107","author":"Rasmusson","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101127_b0055","doi-asserted-by":"crossref","unstructured":"Woo S, Becker AS, Tong A, et al. Identification of Key Anatomic Structures on Magnetic Resonance Imaging During Prostate Stereotactic Body Radiation Therapy for Dose Avoidance to Reduce Erectile Dysfunction Risk.Pract Radiat Oncol. Published online June 30, 2025. https:\/\/doi.org\/10.1016\/j.prro.2025.06.005.","DOI":"10.1016\/j.prro.2025.06.005"},{"issue":"4","key":"10.1016\/j.ctro.2026.101127_b0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ijrobp.2023.12.037","article-title":"Urethra-Sparing Prostate Cancer Stereotactic Body Radiation Therapy: Sexual Function and Radiation Dose to the Penile Bulb, the Crura, and the Internal Pudendal arteries from a Randomized phase 2 Trial","volume":"119","author":"Achard","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101127_b0065","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2024.06.030","article-title":"Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a prospective Study","volume":"120","author":"Arcangeli","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101127_b0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamaoncol.2021.0039","article-title":"Safety and Efficacy of Virtual Prostatectomy with Single-Dose Radiotherapy in patients with Intermediate-Risk Prostate Cancer: results from the PROSINT phase 2 Randomized Clinical Trial","volume":"7","author":"Greco","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101127_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110181","article-title":"ONE SHOT - single shot radiotherapy for localized prostate cancer: 18-month results of a single arm, multicenter phase I\/II trial","volume":"194","author":"Zilli","year":"2024","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101127_b0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101127_b0085","article-title":"Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities. Clin Transl","volume":"45","author":"Gomez-Iturriaga","year":"2024","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101127_b0090","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0360-3016(02)02805-5","article-title":"Penile bulb imaging","volume":"53","author":"Wallner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101127_b0095","doi-asserted-by":"crossref","unstructured":"Teunissen FR, Wortel RC, Wessels FJ, et al. Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.Clin Transl Radiat Oncol. 2021;32:29-34. Published 2021 Nov 14. https:\/\/doi.org\/10.1016\/j.ctro.2021.11.005.","DOI":"10.1016\/j.ctro.2021.11.005"},{"issue":"2","key":"10.1016\/j.ctro.2026.101127_b0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ctro.2026.101127_b0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.prro.2024.05.009","article-title":"Urinary Organs at risk for Prostate Cancer External Beam Radiation Therapy: Contouring guidelines on Behalf of the Francophone Group of Urological Radiation Therapy","volume":"14","author":"Le Gu\u00e9velou","year":"2024","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101127_b0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijrobp.2004.04.070","article-title":"Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI","volume":"61","author":"McLaughlin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101127_b0115","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ijrobp.2004.01.042","article-title":"The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy","volume":"59","author":"Buyyounouski","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101127_b0120","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/S1470-2045(16)00063-2","article-title":"Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy","volume":"17","author":"Lee","year":"2016","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101127_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jsxm.2019.03.273","article-title":"Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy for Prostate Cancer","volume":"16","author":"Nascimento","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.ctro.2026.101127_b0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2022.04.022","article-title":"Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy","volume":"171","author":"Willigenburg","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101127_b0135","article-title":"Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: the dosimetric impact.Tech Innov Patient support","volume":"21","author":"Smith","year":"2022","journal-title":"Radiat Oncol"},{"issue":"1119","key":"10.1016\/j.ctro.2026.101127_b0140","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200433","article-title":"Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function","volume":"94","author":"Hwang","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2026.101127_b0145","doi-asserted-by":"crossref","unstructured":"Teunissen FR, van der Voort van Zyp JRN, Verkooijen HM, Wortel RC. Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment. J Sex Med. 2022;19(7):1196-1200. https:\/\/doi.org\/10.1016\/j.jsxm.2022.04.006.","DOI":"10.1016\/j.jsxm.2022.04.006"},{"key":"10.1016\/j.ctro.2026.101127_b0150","doi-asserted-by":"crossref","unstructured":"Teunissen FR, Wortel RC, Hes J, et al. Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients. Phys Imaging Radiat Oncol. 2021;20:5-10. Published 2021 Sep 21. https:\/\/doi.org\/10.1016\/j.phro.2021.09.002.","DOI":"10.1016\/j.phro.2021.09.002"},{"key":"10.1016\/j.ctro.2026.101127_b0155","article-title":"Neurovascular bundle sparing in hypofractionated radiotherapy maintained with realistic treatment uncertainties.Phys Imaging","volume":"33","author":"Kwakernaak","year":"2025","journal-title":"Radiat Oncol"},{"issue":"6suppl","key":"10.1016\/j.ctro.2026.101127_b0160","volume":"38","author":"Desai","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101127_b0165","first-page":"5","article-title":"DESTINATION 1 preliminary dosimetry analysis","volume":"38","author":"Cooper","year":"2020","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101127_b0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.euo.2023.08.003","article-title":"Sexual Structure Sparing for Prostate Cancer Radiotherapy: a Systematic Review","volume":"7","author":"Le Guevelou","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ctro.2026.101127_b0175","doi-asserted-by":"crossref","unstructured":"Murray J, Gulliford S, Griffin C, et al. Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.Clin Transl Radiat Oncol. 2019;21:77-84. Published 2019 Dec 31. https:\/\/doi.org\/10.1016\/j.ctro.2019.12.006.","DOI":"10.1016\/j.ctro.2019.12.006"},{"issue":"2","key":"10.1016\/j.ctro.2026.101127_b0180","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijrobp.2009.07.1748","article-title":"Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial","volume":"78","author":"Wiegner","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101127_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2020.12.013","article-title":"Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking","volume":"156","author":"Jaccard","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101127_b0190","article-title":"Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical changes in Dose-Escalated Linac-based SBRT","volume":"15(4):1153","author":"Faccenda","year":"2023","journal-title":"Cancers"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:26:02Z","timestamp":1774671962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S2405630826000224"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101127","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between dose to specific pelvic substructures and urinary and sexual dysfunction following Single-Dose ablative radiotherapy for prostate Cancer: A post hoc analysis from the ABRUPT trial","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101127"}}